Sam Hall is the Co-Founder & Managing Partner of Scion Life Sciences, a venture capital fund focusing on biotechnology companies dedicated to developing new medicines. Sam has also worked as a Director at Stoke Therapeutics, Chinook Therapeutics, Ascidian Therapeutics, Marengo Therapeutics, and Syntimmune. Additionally, Sam was a Partner at Apple Tree Partners and an Associate at Symphony Capital. Sam's educational background includes a degree in Molecular Biology from Princeton University, and MPhil and PhD degrees in Immunology from the University of Cambridge.
This person is not in any teams